secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001104659-26-021893
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health FY2025 revenue $3.18B (+56% YoY), adjusted EBITDA $205.4M; material weakness delays 10-K filing
--------------------------------------------------------------------------------

- FY2025 total revenue $3.18B (+56% YoY); at high end of guidance; Care Partners revenue $3.02B (+55%).
- Adjusted EBITDA $205.4M (+21% YoY); adjusted diluted EPS $2.20; net income $22.5M, GAAP EPS $0.46.
- Q4 revenue $950.5M (+43% YoY); adjusted EBITDA $52.5M (+50%); adjusted EPS $0.54.
- Board doubled share repurchase authorization to $100M; $35.9M remained at Dec 31, 2025.
- Anticipates material weakness in internal controls over acquisition/purchase accounting; expects to file 10-K within 15-day extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926021893/0001104659-26-021893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926021893/tm267656d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-021893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer